NCT00069719View on ClinicalTrials.gov

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 1999

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Glaucoma therapy

Trial Locations (1)

Unknown

Alcon Clinical Trial Sites, Multiple Locations Throughout the US Sponsored by Alcon of

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00069719 - Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients | Biotech Hunter | Biotech Hunter